STRATEGIC OBJECTIVES

• Search for biomarkers, based on B cell epitopes and microRNA expression, to improve the diagnosis and treatment of food allergy.
• To measure the quality of life and socioeconomic costs associated with food allergy.
• To develop technological instruments for monitoring food allergy in patients undergoing immunotherapy. 
• To assess the usefulness of the “in vitro” techniques of basophils activation and interleukins determination for the diagnosis and monitoring of desensitization treatment with chemotherapeutic agents and biological drugs. 
• To assess the quality of life and associated costs of drug desensitization procedures. 
• To assess the frequency of mast cell disease in patients with anaphylaxis.
• To assess risk factors for severe asthma.
• Technological and clinical validation of a respiratory exposure chamber against aeroallergens.Validación tecnológica y clínica de una cámara de exposición respiratoria frente a aeroalérgenos.

RESEARCH LINES

• Diagnosis and treatment of food allergy. 
• Diagnosis and treatment of allergy to chemotherapeutic and biological drugs.
• Anaphylaxis and mastocytosis.
• Respiratory allergy.